The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 03, 2024

Filed:

Dec. 09, 2021
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Kathryn M. Camacho, Los Angeles, CA (US);

Stefano Menegatti, Raleigh, NC (US);

Sunny Kumar, Aliso Viejo, CA (US);

Douglas Vogus, Goleta, CA (US);

Samir Mitragotri, Lexington, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/61 (2017.01); A61K 31/4745 (2006.01); A61K 31/704 (2006.01); A61K 31/7068 (2006.01);
U.S. Cl.
CPC ...
A61K 47/61 (2017.08); A61K 31/4745 (2013.01); A61K 31/704 (2013.01); A61K 31/7068 (2013.01);
Abstract

Pharmaceutical compositions comprising two or more therapeutically active agents, such as two or more anticancer agents, conjugated to one or more biocompatible polymers, wherein the molar ratio of the agents and/or schedules of delivery provide a synergistic therapeutic effect, are described. Methods of making and using the pharmaceutical compositions are further described. In one embodiment, the pharmaceutical compositions contain topoisomerase I and topoisomerase II inhibitors conjugated to the same or different biocompatible polymers. The two or more anticancer agents are covalently coupled to the polymer(s), and thereby can be delivered to a tumor at a molar ratio which provides a synergistic effect. Optionally, the agents are coupled indirectly to the polymer(s) via a linker.


Find Patent Forward Citations

Loading…